Pulse Biosciences, Inc. (PLSE) Earnings History
Net Loss12 years of earnings data (2014–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Pulse Biosciences, Inc. (PLSE) Earnings Overview
As of July 8, 2026, Pulse Biosciences, Inc. (PLSE) reported trailing twelve-month net income of -$75M, reflecting -17.4% year-over-year growth. The company earned $-1.10 per diluted share over the past four quarters, with a net profit margin of -20794.6%.
Looking at the long-term picture, PLSE's historical earnings data spans multiple years. The company achieved its highest annual net income of -$474,857 in fiscal 2014.
Pulse Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including INVA ($504M net income, 63.8% margin), NVCR (-$173M net income, -20.8% margin), ATEC (-$125M net income, -18.8% margin), PLSE has room to improve margins relative to the peer group. Compare PLSE vs INVA →
PLSE Earnings vs Peers
Earnings metrics vs comparable public companies
PLSE Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$73M | -35.8% | -$77M | $-1.08 | -20794.6% | -21982.6% |
| 2024 | -$54M | -26.9% | -$56M | $-0.92 | - | - |
| 2023 | -$42M | +27.9% | -$44M | $-0.88 | - | - |
| 2022 | -$59M | +8.1% | -$58M | $-1.72 | -8357.9% | -8293.9% |
| 2021 | -$64M | -28.0% | -$63M | $-2.28 | -4489.4% | -4443.9% |
| 2020 | -$50M | -8.2% | -$50M | $-2.14 | - | - |
| 2019 | -$46M | -22.5% | -$48M | $-2.22 | - | - |
| 2018 | -$38M | -46.8% | -$38M | $-2.20 | - | - |
| 2017 | -$26M | -168.6% | -$26M | $-1.73 | - | - |
| 2016 | -$10M | -238.6% | -$10M | $-0.86 | - | - |
| 2015 | -$3M | -492.0% | -$4M | $-0.37 | - | - |
| 2014 | $-474,857 | - | $-308,571 | $-0.19 | - | - |
Download Data
Export PLSE earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PLSE — Frequently Asked Questions
Quick answers to the most common questions about buying PLSE stock.
What is PLSE earnings per share (EPS)?
PLSE trailing twelve-month (TTM) diluted EPS is $-1.10, reflecting -17.4% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2014 to 2025 is available in the table on this page.
What is Pulse Biosciences, Inc.'s net income?
Pulse Biosciences, Inc. (PLSE) trailing twelve-month net income is $-75M as of 2025. Earnings declined -17.4% year-over-year.
Is PLSE profitable?
PLSE is not currently profitable on a TTM basis, reporting a net loss of $-75M. Net margin is -20794.6%. Investors should monitor for a return to profitability.
What is PLSE's earnings growth rate?
PLSE compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2014 to 2025.
What are PLSE's profit margins?
Pulse Biosciences, Inc. net profit margin is -20794.6%, operating margin is -21982.6%, and gross margin is -360.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -74.4%.
Is PLSE growing earnings?
PLSE earnings are declining — EPS fell -17.4% year-over-year. TTM net income dropped to $-75M. This contrasts with the 5-year CAGR of N/A.
What was PLSE's best earnings year?
Pulse Biosciences, Inc.'s highest annual net income on record is $-474857.00, achieved in fiscal year 2014. Earnings history on this page spans 2014 to 2025 and includes all annual and quarterly figures.
What were PLSE's earnings last quarter?
PLSE's most recent reported quarter was Q1 2026. Net income was $-19M with diluted EPS of $-0.26. For a full breakdown of all quarters, see the quarterly earnings table on this page.